Thursday, 19 Jul 2018

You are here

Kevin Winthrop, MD: H. zoster and tofacitinib: the risk of concomitant nonbiologic therapy

Dr. Kevin Winthrop, associate professor of infectious diseases at Oregon Health & Sciences University in Portland, Oregon, discusses abstract 559.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Dr. Cassie Calabrese: Clinical...

23 Jan 2017

The RheumNow Week in Review - 2 March...

05 Mar 2018

Jack Cush, MD: ACR Rheumatology Round-Up

16 Nov 2015

Dr. Bill Shergy: Handling DMARDs and...

19 Dec 2016

RheumNow Week in Review - 19 May 2016

20 May 2016

The RheumNow Week in Review – 17 May...

22 May 2017

The RheumNow Week in Review - 17...

17 Nov 2017

The RheumNow Week in Review – Life...

29 Jun 2018

Dr. Naomi Schlesinger - Complete...

15 Jun 2017

Dr. Arthur Kavanaugh Discusses RheumNow

08 Nov 2015

RWCS 2017: Unusual Case of...

21 Feb 2017

Dr. Raman Bains: Rapid digital gangrene...

02 Mar 2016